PGY-2 Medication-Use Safety & Policy

PGY-2 Medication-Use Safety & Policy


Memorial Sloan Kettering (MSK) is pleased to offer a 12-month post-graduate training program that provides advanced training in medication-use safety, quality assessment, and drug policy. The program offers a diverse experience designed to develop the resident’s skills in medication safety principles, leadership, process improvement, drug information, institutional policy development, planning, and research.

The resident will be prepared to assume a leadership position to implement sustained medication-use and quality improvement strategies and manage formulary and drug policies for adult and pediatric patients. The resident will use our fully integrated electronic medical record and a library of comprehensive drug guidelines for virtually all medications used in cancer patients. The resident will also utilize our robust electronic reporting system to dissect actual events and trend improvement efforts that enhance the care of our patients. The resident will interact with our experienced pharmacy staff that operates in one of the country’s most comprehensive pharmacy systems, including a large team of clinical pharmacy specialists. The resident will also learn about the medication use challenges in one of the world’s most extensive investigational drug programs with an NCI- supported research pharmacy. The resident will attend several interdisciplinary institutional committees, including Pharmacy and Therapeutics, Pharmacy Quality Assessment, and Medication Management. The resident will learn how to be a confident presenter by delivering monthly didactic presentations, including medication safety pearls, journal clubs, and pharmacy grand rounds programs.

Required Rotations

Educational rotations will include:

  • Comprehensive Orientation Program to All Systems
  • Medication Safety Leadership [longitudinal]: Joint Commission Medication Management Standards, ISMP/IHI guidelines, Evaluating the Literature, Just Culture, Root Cause Analysis
  • Pharmacy Operations [longitudinal]: Focus on Technology and Standardizing the Medication-use system
  • Drug Policy [longitudinal]: Formulary Management, Therapeutic Guidelines, National Patient Safety Goals, Regulatory Readiness, Drug Shortages, and FDA mandates
  • Medication Event Analysis [longitudinal]: Dissect and trend actual and close-call events; appropriate application of health information technology, including clinical decision support, automation system, and smart infusion pumps.
  • Investigational Drug Service [longitudinal]
  • Material Management: Supply chain, drug shortage management, narcotic surveillance
  • Clinical Rotations with Pharmacy Specialists/Clinical Coordinators in Geriatrics, Pediatric Oncology, Adult Critical Care, Transitions of Care, and Pain Management
  • Research Project with the explicit goal of publication in a peer-reviewed publication

Application Deadline

January 14th

Length of Program

One year

Number of Positions



  • Successful completion of an ACPE accredited Doctor of Pharmacy program
  • Successful completion of an ASHP accredited PGY-1 Pharmacy Practice Residency
  • Eligibility for pharmacist licensure in New York State (Residents are required to obtain Pharmacist licensure in the State of New York by October 1st)

How to Apply

Interested candidates should submit the following through Pharmacy Online Residency Centralized Application (PhORCAS):

  • Letter of interest explaining career goals
  • Three letters of recommendation (standard PhORCAS format)
  • Academic transcript
  • Curriculum Vitae

Additional Information

Frequently Asked Questions
Residency Program Preceptors
Residency Learning Experiences and Teaching Activities


Amelia Chan, PharmD, MBA, MS, BCOP
Assistant Director, Drug Policy Management, Quality, & Safety Medication-Use Safety and Policy PGY-2 Residency Program Director
Memorial Sloan Kettering Cancer Center
321 E 61st St, Room 566
New York, NY 10065
[email protected]